Cite
MLA Citation
T. Shien et al.. “313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial).” Annals of oncology, vol. 28, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100097079069.0x000031